Physician profile
Lu Chen
NPI 1861717282
$15,103.03
in general payments reported to CMS, 2019-2025
14 companies · $9,066 in 2025
The $9,066 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $127 · 2022: $331 · 2023: $3,724 · 2024: $1,730 · 2025: $9,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,207 · Grant: $3,625 · Food and Beverage: $2,117 · Consulting Fee: $398 · Honoraria: $100 · Education: $71.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,207.22 |
| Grant | $3,625.00 |
| Food and Beverage | $2,117.13 |
| Consulting Fee | $398.00 |
| Honoraria | $100.00 |
| Education | $71.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $7,816.77 | 2021-2025 | Acticor 7 Vr-T Dx |
| Medtronic, INC. | $3,625.00 | 2023 | |
| Abbott Laboratories | $2,033.26 | 2021-2025 | Ensite, Na, Tacticath Ablation Catheter, Sensor Enabled |
| Biosense Webster, INC. | $438.48 | 2025 | Carto 3 |
| Ge Healthcare | $398.00 | 2025 | |
| Boston Scientific Corporation | $140.18 | 2021-2025 | Farapulse |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2019 | |
| Abbvie INC. | $124.93 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $100.02 | 2025 | Opsumit, Uptravi |
| Artrya Ltd. | $100.00 | 2025 | |
| Kestra Medical Technology Services, INC. | $84.68 | 2025 | Assure Wcd |
| Pfizer INC. | $78.48 | 2024 | |
| Edwards Lifesciences Corporation | $24.38 | 2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lu Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.